Asterias Biotherapeutics, Inc.·4

Feb 18, 9:25 PM ET

Asterias Biotherapeutics, Inc. 4

4 · Asterias Biotherapeutics, Inc. · Filed Feb 18, 2015

Insider Transaction Report

Form 4
Period: 2015-02-13
SEGALL JUDITH
DirectorCorporate Secretary
Transactions
  • Award

    Stock Option (right to buy)

    2015-02-13+20,00020,000 total
    Exercise: $3.90Exp: 2025-02-12Series A Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]These options will vest and become exercisable in 48 equal monthly installments beginning on the one month anniversary of the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION